Literature DB >> 198424

Reversible gonadotropin deficiency in male Cushing's disease.

J P Luton, P Thieblot, J C Valcke, J A Mahoudeau, H Bricaire.   

Abstract

Twelve adult males with documented active Cushing's disease were studied. Mean plasma testosterone (T) was significantly decreased: 1.8 +/- 0.3 (SEM) ng/ml (N=6.8 +/- 0.5); gonadotropin measurements in 8 patients, in basal conditions and under LH-RH iv, showed a significant decrease in both FSH and LH. A further study of 11 patients in remission of Cushing's disease indicated a significant increase in plasma T and gonadotropins up to the normal range. One patient with an initial low T value had a normalized T while in remission, then a dramatic decrease when the disease relapsed. We conclude: a hypogonadotropic hypogonadism is found in male Cushing's disease; it disappears as early as hypercortisolism is suppressed. Some possible mechanisms are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 198424     DOI: 10.1210/jcem-45-3-488

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

1.  Treatment with a CRH-R1 antagonist prevents stress-induced suppression of the central neural drive to the reproductive axis in female macaques.

Authors:  S M Herod; C R Pohl; J L Cameron
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-09-07       Impact factor: 4.310

2.  Sensitivity to stress-induced reproductive dysfunction is associated with a selective but not a generalized increase in activity of the adrenal axis.

Authors:  S M Herod; A M Dettmer; M A Novak; J S Meyer; J L Cameron
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-19       Impact factor: 4.310

Review 3.  Corticosteroid-Induced osteoporosis: detection and management.

Authors:  J D Adachi; A Papaioannou
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

4.  Hypogonadotropic Hypogonadism in Males with Glycogen Storage Disease Type 1.

Authors:  Evelyn M Wong; Anna Lehman; Philip Acott; Jane Gillis; Daniel L Metzger; Sandra Sirrs
Journal:  JIMD Rep       Date:  2017-02-04

5.  Hypothalamic-pituitary function in Cushing's disease.

Authors:  D Le Roith; M S Shapiro; A Gutman; I M Spitz
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

Review 6.  Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.

Authors:  G Arnaldi; T Mancini; G Tirabassi; L Trementino; M Boscaro
Journal:  J Endocrinol Invest       Date:  2012-04       Impact factor: 4.256

Review 7.  Epidemiology of Male Hypogonadism.

Authors:  Arthi Thirumalai; Bradley D Anawalt
Journal:  Endocrinol Metab Clin North Am       Date:  2022-02-08       Impact factor: 4.748

8.  Annexin 1 (lipocortin 1) mimics inhibitory effects of glucocorticoids on testosterone secretion and enhances effects of interleukin-1beta.

Authors:  Patricia O Cover; Frederick Baanah-Jones; Christopher D John; Julia C Buckingham
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

9.  Anterior pituitary function after adrenalectomy in patients with Cushing's syndrome.

Authors:  M Marazuela; C Cuerda; T Lucas; A Vicente; C Blanco; J Estrada
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

10.  Control of circadian and episodic variations of adrenal androgens secretion in man.

Authors:  C Lejeune-Lenain; E Van Cauter; D Désir; M Beyloos; J R Franckson
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.